Repeat: The drugs also hold out the promise of treatments for other diseases that involve myelin loss or dysfunction, including cerebral palsy, age-related dementia, optic neuritis and schizophrenia, the scientists believe.
The drugs also hold out the promise of treatments for other diseases that involve myelin loss or dysfunction, including cerebral palsy, age-related dementia, optic neuritis and schizophrenia, the scientists believe.